Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions

Medicine & Life Sciences

• Insulin-Like Growth Factor I 100%
• Growth Hormone 94%
• Breast 75%
• Human Mammary Glands 54%
• Hormones 34%
• Hyperplasia 32%
• IGF Type 1 Receptor 31%
• Breast Neoplasms 23%
• Progesterone 23%
• pegvisomant 20%
• Estrogens 20%
• Intercellular Signaling Peptides and Proteins 20%
• Insulin-Like Growth Factor Binding Protein 5 19%
• Genomic Imprinting 17%
• Insulin-Like Growth Factor Binding Protein 1 16%
• Carcinoma 16%
• Genetically Modified Animals 15%
• Luteal Phase 14%
• Chemoprevention 13%
• Puberty 13%
• Somatostatin 12%
• Plastics 11%
• Estrogen Receptors 11%
• Cell Culture Techniques 9%
• Animal Models 8%
• Neoplasms 7%
• Mutation 6%
• Animals 6%
• Genes 4%